Phloroglucinol Inhibits the in vitro Differentiation Potential of CD34 Positive Cells into Endothelial Progenitor Cells

Inhibiting the bioactivities of circulating endothelial progenitor cells (EPCs) results in significant inhibition of neovessel formation during tumor angiogenesis. To investigate the potential effect of phloroglucinol as an EPC inhibitor, we performed several in vitro functional assays using CD34(+)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Yi-Hong, Lee, Jun-Hee, Jung, Seok-Yun, Kim, Jae-Won, Lee, Sang-Hun, Lee, Dong-Hyung, Lee, Kyu-Sup, Lee, Boo-Yong, Kwon, Sang-Mo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Applied Pharmacology 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792212/
https://www.ncbi.nlm.nih.gov/pubmed/24116289
http://dx.doi.org/10.4062/biomolther.2012.20.2.158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792212/
https://www.ncbi.nlm.nih.gov/pubmed/24116289
http://dx.doi.org/10.4062/biomolther.2012.20.2.158

Ejemplares similares